Similar to This
Evotec: Analyst sees 125 percent share price potential - | The details: Evotec struggles financially, receives milestone payments and BARDA deal; Berenberg ...
deraktionaer.de/artikel/pharma-biotech/evotec-analyst-sieht-125-prozent-kurschance-die-details-20398004.html
Evotec: Analyst sees 125 percent share price potential - | The details
Evotec: Share at the top of the MDAX - | this is the reason: Evotec plans to sell biologics site to Sandoz for $300 million to promote capital-light model.
deraktionaer.de/artikel/pharma-biotech/evotec-aktie-an-mdax-spitze-das-ist-der-grund-20384104.html
Evotec: Share at the top of the MDAX - | this is the reason
Evotec: Share price collapses massively - | what's going on?: Evotec share price plummets after lowered sales forecast; EBITDA targets remain the same.
deraktionaer.de/artikel/pharma-biotech/evotec-aktie-bricht-massiv-ein-was-ist-da-los-20383542.html
Evotec: Share price collapses massively - | what's going on?
Evotec: Shares are being passed on again: Evotec shares fall by 7%.
deraktionaer.de/artikel/aktien/evotec-aktie-wird-wieder-durchgereicht-20380889.html
Evotec: Shares are being passed on again
Evotec jumps share price - | strongest stock in the MDAX ahead of Traton and Bilfinger
deraktionaer.de/artikel/pharma-biotech/evotec-mit-kurssprung-staerkster-wert-im-mdax-vor-traton-und-bilfinger-20380744.html
Evotec jumps share price - | strongest stock in the MDAX ahead of Traton ...
San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer
sandiegouniontribune.com/2024/11/22/san-diegos-halozyme-withdraws-proposed-2-1b-acquisition-of-evotec/
San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after ...
Key FactsEvotec's MDAX Comeback on the Horizon
Nov 22, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
  • Evotec may be poised for a return to the MDAX by the end of the year, as JPMorgan predicts the company's inclusion in the mid-cap index.

  • Halozyme Therapeutics has made a takeover offer for Evotec at 11 euros per share, valuing the company at around two billion euros.

  • Despite the stock briefly rising to 10.69 euros, it is currently hovering around the 10-euro mark, while Evotec aims to resist the takeover attempt.

  • For a successful deal, higher bids will be necessary, and Evotec must regain investor confidence to ensure long-term success.
Evotec: Extreme Ausschläge: Evotec shares lose over 50% on an annual basis, but recover with 51.9% in a 1-month comparison as the SDAX leader.
deraktionaer.de/artikel/pharma-biotech/evotec-extreme-ausschlaege-20370001.html
Evotec: Extreme Ausschläge
Key FactsEvotec: Stock Shows Extreme Transformation
Nov 14, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
  • Evotec's stock experienced a significant decline of over 50% last year but is now the top SDAX performer with a 51.9% monthly increase.

  • New CEO Christian Wojczewski announced progress on strategic initiatives aimed at long-term growth.

  • Speculation of a takeover arose as Triton acquired 9.16% of Evotec's voting rights, although the company denied any discussions.

  • Regaining investor confidence is crucial for Evotec, which needs to deliver important news in the coming months.
Evotec: Important dates in the coming week: Evotec shares remain weak; CEO Wojczewski buys shares; company drops from MDAX.
deraktionaer.de/artikel/pharma-biotech/evotec-wichtige-termine-in-der-kommenden-woche-20366697.html
Evotec: Important dates in the coming week
Evotec after the crash - | is the bottom now forming?: Evotec shares are stabilizing; short sales are falling, important investor events in November.
deraktionaer.de/artikel/pharma-biotech/evotec-nach-dem-crash-gelingt-jetzt-die-bodenbildung-20364447.html
Evotec after the crash - | is the bottom now forming?
Evotec: "Sell" twice: Evotec shares stabilize after price slide near €6, analysts remain skeptical.
deraktionaer.de/artikel/aktien/evotec-zweimal-verkaufen-20364246.html
Evotec:
MDAX leader thanks to Pfizer: Is the Evotec share finally turning up again on the stock market?
boerse-online.de/nachrichten/aktien/mdax-spitzenreiter-dank-pfizer-dreht-die-evotec-aktie-jetzt-an-der-boerse-endlich-wieder-auf-20361451.html
MDAX leader thanks to Pfizer: Is the Evotec share finally turning up again ...
Evotec: Will this gap actually be closed?: Evotec shares fall to lowest level since 2017; Analyst recommends selling, sees risks and price target of 7.00 euros.
deraktionaer.de/artikel/technischeanalyse/evotec-wird-dieses-gap-tatsaechlich-noch-geschlossen-20359891.html
Evotec: Will this gap actually be closed?
Evotec after the horror crash - was that it?: Evotec shares fall below 10 euros; new CEO and cost-cutting plan fail to reassure investors.
deraktionaer.de/artikel/pharma-biotech/evotec-nach-dem-horror-crash-wars-das-20356124.html
Evotec after the horror crash - was that it?
Evotec: Deutsche Bank says “Buy” - Share top winner in the MDAX: Evotec shares rise 7% after upgrade to “Buy” by Deutsche Bank with a price target of 19 euros.
deraktionaer.de/artikel/pharma-biotech/evotec-deutsche-bank-sagt-kaufen-aktie-top-gewinner-im-mdax-20355091.html
Evotec: Deutsche Bank says “Buy” - Share top winner in the MDAX
Evotec: Shares in positive territory again - that inspires: Evotec Stock Rebounds, Supported by Positive Conference Call and Analyst Praise; Short selling ...
deraktionaer.de/artikel/pharma-biotech/evotec-aktie-erneut-im-plus-das-befuegelt-20348347.html
Evotec: Shares in positive territory again - that inspires
Evotec: decline stopped - that boosts the share: Evotec shares are stabilizing after a sharp decline, helped by an upgrade from Bank RBC to Outperform ...
deraktionaer.de/artikel/pharma-biotech/evotec-talfahrt-gestoppt-das-befluegelt-die-aktie-20348016.html
Evotec: decline stopped - that boosts the share
Exhausting year: Evotec boss retires, shares fall: The biotech company had to struggle for a long time with the aftermath of a devastating cyber attack ...
faz.net/aktuell/wirtschaft/evotec-chef-zieht-sich-zurueck-die-aktie-faellt-19425176.html
Exhausting year: Evotec boss retires, shares fall